VKTX   $39.33  -3.13% Market Closed After Close 39.031 -0.76%

Viking Therapeutics Inc
Total Cash 930.44M
totalCashPerShare 8.35
EBITDA
Total Debt 1.24M
quickRatio 36.225
currentRatio 36.467
Total Revenue
debtToEquity 0.135
Revenue/Share
ROA -0.12681
ROE -0.15496
grossProfits
freeCashflow -44.29M
operatingCashflow -74.25M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 6.27B
forwardPE -42.850994
floatShares 105.46M
sharesOutstanding 111.44M
sharesShort 14.39M
sharesShortPriorMonth 15.91M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.76%
Short Ratio help_outline 5.25%
shortPercentOfFloat 0.17%
impliedSharesOutstanding
bookValue 8.179
Price To Book help_outline 7.91
earningsQuarterlyGrowth
netIncomeToCommon -99.15M
trailingEps -0.94%
forwardEps -1.51%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.28 4Q 2024
institutionsCount 549
lastUpdated Nov. 6, 2024, 6:26 p.m.